AFT Pharmaceuticals Limited (ASX:AFP)

AFT Pharmaceuticals Revenue

AFT Pharmaceuticals had revenue of 114.94M NZD in the half year ending September 30, 2025, with 37.47% growth. This brings the company's revenue in the last twelve months to 236.25M, up 19.01% year-over-year. In the fiscal year ending March 31, 2025, AFT Pharmaceuticals had annual revenue of 208.02M with 6.45% growth.

• Revenue (ttm): 236.25M NZD
• Revenue Growth: +19.01%
• P/S Ratio: 1.65
• Revenue / Employee: 1.99M NZD
• Employees: 119
• Market Cap: 342.03M AUD

Revenue Chart

* This company reports financials in NZD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	208.02M	12.61M	6.45%
Mar 31, 2024	195.41M	38.77M	24.75%
Mar 31, 2023	156.64M	26.33M	20.20%
Mar 31, 2022	130.31M	17.21M	15.22%
Mar 31, 2021	113.11M	7.51M	7.11%